TW200720656A - Prediction of prognosis of liver disease associated with hepatitis c virus infection - Google Patents

Prediction of prognosis of liver disease associated with hepatitis c virus infection

Info

Publication number
TW200720656A
TW200720656A TW095114055A TW95114055A TW200720656A TW 200720656 A TW200720656 A TW 200720656A TW 095114055 A TW095114055 A TW 095114055A TW 95114055 A TW95114055 A TW 95114055A TW 200720656 A TW200720656 A TW 200720656A
Authority
TW
Taiwan
Prior art keywords
hepatitis
amino acid
peptide
prediction
liver disease
Prior art date
Application number
TW095114055A
Other languages
English (en)
Chinese (zh)
Inventor
Kyogo Itoh
Michio Sata
Shigeru Yutani
Nobukazu Komatsu
Akira Yamada
Original Assignee
Univ Kurume
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kurume filed Critical Univ Kurume
Publication of TW200720656A publication Critical patent/TW200720656A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW095114055A 2005-04-19 2006-04-19 Prediction of prognosis of liver disease associated with hepatitis c virus infection TW200720656A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005121293 2005-04-19

Publications (1)

Publication Number Publication Date
TW200720656A true TW200720656A (en) 2007-06-01

Family

ID=37115194

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095114055A TW200720656A (en) 2005-04-19 2006-04-19 Prediction of prognosis of liver disease associated with hepatitis c virus infection

Country Status (3)

Country Link
JP (1) JP4615567B2 (ja)
TW (1) TW200720656A (ja)
WO (1) WO2006112482A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004285019B9 (en) 2003-10-27 2011-11-24 Vertex Pharmaceuticals Incorporated HCV NS3-NS4A protease resistance mutants
US7705138B2 (en) 2005-11-11 2010-04-27 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
NZ568324A (en) * 2005-11-11 2012-01-12 Vertex Pharma Hepatitis C virus variants
WO2010050181A1 (ja) * 2008-10-27 2010-05-06 株式会社グリーンペプタイド Ｃ型肝炎ウイルスによる肝癌の発症および再発予防ワクチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3055793B2 (ja) * 1990-09-07 2000-06-26 財団法人化学及血清療法研究所 非ａ非ｂ型肝炎ウイルス融合ペプチドおよびその製法
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
CN102659922B (zh) * 2003-09-22 2013-11-06 株式会社绿多肽 来源于c型肝炎病毒的肽

Also Published As

Publication number Publication date
WO2006112482A1 (ja) 2006-10-26
JP4615567B2 (ja) 2011-01-19
JPWO2006112482A1 (ja) 2008-12-11

Similar Documents

Publication Publication Date Title
Carcamo et al. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients
WO2008070727A3 (en) Recombinant antibodies against hepatitis c virus and methods of obtaining and using same
WO2002089731A3 (en) Agents for treatment of hcv and methods of use
US6416946B1 (en) Methods of typing hepatitis C virus and reagents for use therein
WO2008031051A3 (en) Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
DE602006015642D1 (de) Hcv-replikationshemmer
ATE492563T1 (de) Vollständige humane monoklonale antikörper gegen il-13
WO2004111082A3 (fr) Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique
WO2009014216A1 (ja) Ｃ型肝炎ウイルス（hcv）に対して感染阻害活性を有する抗体およびその用途
TW200720656A (en) Prediction of prognosis of liver disease associated with hepatitis c virus infection
WO2007064844A3 (en) Anti-viral griffithsin compounds, compositions, and methods of use
NO20051715L (no) HCV assay
Tanaka et al. Natural history of acute hepatitis C
ATE303597T1 (de) Hcv mosaik antigen zusammensetzung
TW200513260A (en) Hepatitis C virus derived peptides
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
Karamitros et al. Detection of specific antibodies to HCV‐ARF/CORE+ 1 protein in patients treated with pegylated interferon plus ribavirin
Gane et al. Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation
EP1310796A3 (en) Reagents for the simultaneous detection of HCV core antigens and antibodies
Fabris et al. Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection
JP2007117090A5 (ja)
DK1417233T3 (da) Humant rekombinant antistof mod det hepatitis C (HCV) ikke-strukturelle NS3-protein, nukleinsyre og anvendelser deraf
EP1310512A3 (en) Hcv core protein sequences
TW200626726A (en) Hybridoma cell line producing monoclonal antibodies against foot-and-mouth disease virus and the monoclonal antibodies therefrom
Zhu et al. Analysis of complement‐bound HCV complexes using a novel immuno‐capture RT‐PCR method